[Therapeutic evaluation of a new antihistaminic: HS-592].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004485:Eczema / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011537:Pruritus / Q000188:drug therapy; D011759:Pyrrolidines / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy; D014581:Urticaria / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines
Ensaio terapêutico com um nôvo anti-histamínico: HS-592.